Drugmakers raise 2018 U.S. prices, stick to self-imposed limits
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- US stocks close down as oil spikes 12%, job market weakens
- U.S. nonfarm payroll employment unexpectedly falls in February
- Oracle stock falls on report of scrapped Texas data center plans
- Kuwait cuts oil output as storage fills up
- Boeing reportedly nearing 500-aircraft deal with China ahead of Trump visit
- After-hours movers: Marvell, Samsara, GAP, Cooper Cos.
- After-hours movers: Broadcom, StubHub, Cracker Barrel, Grocery Outlet, Veeva Systems and more
- After-hours movers: Moderna, CrowdStrike, Ross Stores, Box and more
- After-hours movers: MongoDB, Credo, SoFi Technologies and more
- After-hours movers: Dell, Block, CoreWeave, Autodesk, MARA and more
Allergen (AGN) PT Lowered to $203 at BofA/Merrill Lynch; 'Cost Restructuring Mitigates Near-Term Headwinds... $300M-400M in Net Savings for 2018E'
January 4, 2018 6:20 AM UTCBofA/Merrill Lynch lowered its price target on Allergen (NYSE: AGN) to $203.00 (from $204.00) while maintaining a Buy rating, following the company's announced cost-cutting measures for 2018.
Analyst Jason Gerberry notes a reduced price target on the shares, as the company announced cost-cutting measures for 2018,... More
Horizon Pharma (HZNP) PT Raised to $18 at Citi on 2018 Outlook; 'Remain Constructive... Stability in Primary Care Franchise'
January 4, 2018 6:12 AM UTCCiti raised its price target on Horizon Pharma (NASDAQ: HZNP) to $18.00 (from $16.00) while maintaining a Buy rating, following a review of the company's outlook into 2018.
Analyst Liav Abraham notes an increased price target on the shares following an updated outlook for 2018 remains constructive... More
